172
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Cost comparison of four revascularisation procedures for the treatment of multivessel coronary artery disease: a commentary

, MD FRCC, , MSc MA & , MD FRCSC MHSc
Pages 1-2 | Accepted 14 Jan 2008, Published online: 19 Feb 2010

References

  • Babapulle MN, Joseph L, Belisle P, et al. A hierarchical Bayesian meta-analysis of randomised clinical trials of drug-eluting stents. Lancet 2004; 364: 583–591
  • Serruys PW, Unger F, Sousa JE, et al. Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease. New England Journal of Medicine 2001; 344: 1117–1124
  • SoS Investigators. Coronary artery bypass surgery versus percutaneous coronary intervention with stent implantation in patients with multivessel coronary artery disease (the Stent or Surgery trial): a randomised controlled trial. Lancet 2002; 360: 965–970
  • Rodriguez A, Bernardi V, Navia J, et al. Argentine randomized study: coronary angioplasty with stenting versus coronary bypass surgery in patients with multiple-vessel disease (ERACI II): 30-day and one-year follow-up results. ERACI II Investigators. Journal of the American College of Cardiology 2001; 37: 51–58
  • Puskas JD, Williams WH, Mahoney EM, et al. Off-pump vs conventional coronary artery bypass grafting: early and 1-year graft patency, cost, and quality-of-life outcomes: a randomized trial. Journal of the American Medical Association 2004; 291: 1841–1849
  • Cheng DC, Bainbridge D, Martin JE, et al. Does off-pump coronary artery bypass reduce mortality, morbidity, and resource utilization when compared with conventional coronary artery bypass? A meta-analysis of randomized trials. Anesthesiology 2005; 102: 188–203
  • Fuster V. Comparison of two treatments for multivessel coronary artery disease in individuals with diabetes (FREEDOM), ClinicalTrials.gov, NCT00086450
  • Serruys P. SYNTAX study: TAXUS drug-eluting stent versus coronary artery bypass surgery for the treatment of narrowed arteries, ClinicalTrials.gov, NCT00114972
  • Boden WE. Is it time to reassess the optimal timing of coronary artery bypass graft surgery following acute myocardial infarction?. American Journal of Cardiology 2002; 90: 35–38
  • Zaroff JG, di Tommaso DG, Barron HV. A risk model derived from the National Registry of Myocardial Infarction 2 database for predicting mortality after coronary artery bypass grafting during acute myocardial infarction. American Journal of Cardiology 2002; 90: 1–4

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.